Skip to content
Round-UpReport

MBRX

Moleculin Biotech, Inc.

1-for-20 reverse split, effective Oct 20, 2026.

Ratio
1-for-20
Effective date
Oct 20, 2026
Split-adjusted trading
Same as the effective date, or not stated separately
Last day to buy
Oct 19, 2026

Shown only when the effective date is also when split-adjusted trading begins. Prior NYSE session. Calculated, not a filing field.

Be on record by
Filing does not state a record date
Fractional shares
Cash in lieu
Form
8-K

Filed Oct 20, 2026

Instead, the stockholder will be entitled to receive a cash payment in lieu of a fractional share.

From the filing, on fractional shares.

Read the SEC filing

Broker reports

No approved reports yet. If your broker handled this split, send a report.

New round-up filings and broker reports. Unsubscribe any time.